dichlororibofuranosylbenzimidazole has been researched along with Allodynia in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, YM | 1 |
| Chen, SR | 1 |
| Chen, H | 1 |
| Pan, HL | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Allodynia
| Article | Year |
|---|---|
Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor.
Topics: Animals; Calcineurin Inhibitors; Casein Kinase II; Dichlororibofuranosylbenzimidazole; Excitatory Po | 2014 |